Grantham, Mayo, Van Otterloo & Co (GMO)’s Marvell Technology MRVL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,067	Closed	-$493K	–	803
2021 Q1	$493K	Buy	+10,067	New	+$493K	﹤0.01%	702
2019 Q1	–	Sell	-36,000	Closed	-$583K	–	726
2018 Q4	$583K	Buy	+36,000	New	+$597K	﹤0.01%	413
2017 Q4	–	Sell	-321,095	Closed	-$5.75M	–	612
2017 Q3	$5.75M	Sell	321,095 -232,552	-42%	-$3.87M	0.03%	211
2017 Q2	$9.15M	Buy	+553,647	New	+$8.95M	0.05%	193
2017 Q1	–	Sell	-471,352	Closed	-$6.54M	–	620
2016 Q4	$6.54M	Buy	+471,352	New	+$6.42M	0.04%	225
2014 Q1	–	Sell	-59,303	Closed	-$853K	–	616
2013 Q4	$853K	Buy	59,303 +3,453	+6%	+$44.5K	﹤0.01%	473
2013 Q3	$642K	Sell	55,850 -4,487	-7%	-$55.4K	﹤0.01%	512
2013 Q2	$707K	Buy	+60,337	New	+$654K	﹤0.01%	500

Other funds holding MRVL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MRVL Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Marvell Technology (MRVL) in Q2 2021, closing a stake of 10,067 shares — an estimated $493K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MRVL in Q2 2013 and held it in 8 quarters. The position peaked at $9.15M in Q2 2017. 743 funds tracked by Wall St. Rank hold MRVL as of Q2 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Marvell Technology position as of Q2 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,067 Marvell Technology shares in Q2 2021, an estimated $493K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Marvell Technology in Q2 2013 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Marvell Technology position peaked at $9.15M in Q2 2017.
743 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.